LILRB4,also known as CD85k and LIR-5, ILT3, is an approximately 60 kDa transmembrane glycoprotein that negatively regulates immune cell activation. Mature human ILT3 consists of an extracellular domain (ECD) with two Ig-like domains, a transmembrane segment, and a cytoplasmic domain with 3 immunoreceptor tyrosine-based inhibitory motifs (ITIM). The mature ECD of human ILT3 shares 44% amino acid identity with mouse ILT3. Alternative splicing of human ILT3 generates an isoform that lacks the first ITIM and a secreted isoform that circulates in the serum of cancer patients. ILT3 is expressed on dendritic cells (DC), monocytes, macrophages, and vascular endothelial cells.
高纯度、高活性、低内毒素、高批间一致性
产品数据
-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
[93518ES]Recombinant Mouse LILRB4/CD85k/ILT3 Protein,His Tag
[93512ES]Recombinant Cynomolgus LILRB4/CD85k/ILT3 Protein,His Tag
[93502ES]Recombinant Biotinylated Human LILRB4/CD85k/ILT3 Protein,His-Avi Tag
[93393ES]Recombinant Human LILRB4/CD85k/ILT3 Domain 1 Protein,His-Avi Tag
[93320ES]Recombinant Biotinylated Human LILRB4/CD85k/ILT3 Domain 1 Protein,His-Avi Tag
[93292ES]Recombinant Biotinylated Human LILRB4/CD85k/ILT3 Domain 2 Protein,His-Avi Tag
[93527ES]Recombinant Human LILRB4/CD85k/ILT3 Protein,His-Avi Tag